The earlier this change is recognised, the better
Pharmaceutical manufacturers have recently been selling their GLP-1 medications below the list price (around $500 a month) when purchased directly from them and without insurance
The authors conclude that use of GLP-1 agonists probably has little or no effect on risk of breast cancer, kidney cancer, pancreatic cancer, or thyroid cancer ( moderate certainty )
Compounded semaglutide has grown in popularity during shortages, but compounded drugs are not approved by the Food and Drug Administration (FDA)
Rarer ones include gallbladder problems, pancreatitis, and gastroparesis, a chronic stomach condition that can cause serious pain, vomiting, and malnutrition
Effects of GLP1 Analogues and Agonists on the Gut Microbiota: A Systematic Review